Phase I trial of sargramostim/pelareorep therapy in pediatric patients with recurrent or refractory high-grade brain tumors von Schuelke, MR, Gundelach, JH, Coffey, M, West, E, Scott, K, Johnson, DR, Samson, A, Melcher, A, Vile, RG, Bram, RJ

Volltext bestellen

Oncolytic virotherapy induced CSDE1 neo-antigenesis restricts VSV replication but can be targeted by immunotherapy von Kottke, T, Tonne, J, Evgin, L, Driscoll, CB, van Vloten, J, Jennings, VA, Huff, AL, Zell, B, Thompson, JM, Wongthida, P, Pulido, J, Schuelke, MR, Samson, A, Selby, P, Ilett, E, McNiven, M, Roberts, LR, Borad, MJ, Pandha, H, Harrington, K, Melcher, A, Vile, RG

Volltext bestellen

Diverse immunotherapies can effectively treat syngeneic brainstem tumors in the absence of overt toxicity von Schuelke, MR, Wongthida, P, Thompson, J, Kottke, T, Driscoll, CB, Huff, AL, Shim, KG, Coffey, M, Pulido, J, Evgin, L, Vile, RG

Volltext bestellen

APOBEC3B-mediated Corruption of the Tumor Cell Immunopeptidome Induces Heteroclitic Neoepitopes for Cancer Immunotherapy von Driscoll, CB, Schuelke, MR, Kottke, T, Thompson, JM, Wongthida, P, Tonne, JM, Huff, AL, Miller, A, Shim, KG, Molan, A, Wetmore, C, Selby, P, Samson, A, Harrington, K, Pandha, H, Melcher, A, Pulido, JS, Harris, R, Evgin, L, Vile, RG

Volltext bestellen

Selective Disactivation of Neurofibromin GAP Activity in Neurofibromatosis Type 1 (NF1) von Klose, Anja, Reza Ahmadian, M., Schuelke, Markus, Scheffzek, Klaus, Hoffmeyer, Sven, Gewies, Andreas, Schmitz, Frank, Kaufmann, Dieter, Peters, Hartmut, Wittinghofer, Alfred, Nürnberg, Peter

Volltext